QA: Opiant Pharmaceuticals INC in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001385508_2021_Opiant_Pharmaceuticals_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001385508, Opiant Pharmaceuticals INC

  xvar xval
0 AssetsCurrent 59,099,153
1 IntangibleAssetsNetIncludingGoodwill 13,000
2 PropertyPlantAndEquipmentNet 171,190
3 remainder_Assets 1,329,689
4 LiabilitiesCurrent 6,420,244
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 18,700,546
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 11,895,948
9 ResearchAndDevelopmentExpense 9,290,077
10 remainder_Expenses 9,874,421
11 remainder_Revenues 32,864,331
12 remainder_NetIncome 155,622
13 remainder_ComprehensiveNetIncome -776
  yvar yval
0 Assets 60,613,032
1 Liabilities 25,120,790
2 Expenses 31,060,446
3 Revenues 32,864,331
4 StockholdersEquity 35,492,242
5 NetIncome 1,959,507
6 ComprehensiveNetIncome 1,959,119
7 BaseVar 74,907,498
8 EconomicCapitalRatiobeforeLimitedLiability 1.85
9 EconomicCapitalRatio 2.92

Edgar->Model Mapping

Feature Distribution

Change over Time